• Home
  • What is the Optimal Design-Build-Test Cycle for Clinically Relevant Synthetic CAR T Cell Therapies?

What is the Optimal Design-Build-Test Cycle for Clinically Relevant Synthetic CAR T Cell Therapies?

Author List
Chen YY, Lim W, Levings M, Blazar B, Krenciute G, Wong W, Lehner M
Publication
Cell systems
Publication ID (Profile URL)
https://researcherprofiles.org/profile/140164550
Publication Year
2020
PubMed ID
32970992
Publication Title
Chen YY, Lim W, Levings M, Blazar B, Krenciute G, Wong W, Lehner M. What is the Optimal Design-Build-Test Cycle for Clinically Relevant Synthetic CAR T Cell Therapies? Cell Syst. 2020 09 23; 11(3):212-214.